Both in Biotechnology
Fennec Pharmaceuticals vs Kyverna Therapeutics
Over the past year FENC returned +22.9% and KYTX returned −16.0%; their daily moves had a correlation of 0.29.
FENC +22.9% KYTX −16.0%Growth of $1, one year, split-adjusted
| Metric | FENC | KYTX |
|---|---|---|
| Price | $10.24 | $5.67 |
| Market cap | $359.1M | $350.7M |
| Today | −6.48% | −3.08% |
| 1 month | −0.9% | −13.0% |
| 6 months | +56.6% | −36.1% |
| Year to date | +33.0% | −39.7% |
| 1 year | +20.9% | −20.9% |
| Revenue growth (YoY) | +85.2% | — |
| Gross margin | 96.0% | — |
| Net margin | 11.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | — |
| Net cash | $41.2M | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 58.2% |
| Short % of float | 2.2% | 26.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).